Search Results - A. V. Gordeev
- Showing 1 - 20 results of 27
- Go to Next Page
-
1
THE CONCEPT OF BARRIER ORGAN DISEASE IN THE PATHOGENESIS OF SPONDYLOARTHRITIS by E. A. Galushko, A. V. Gordeev
Published 2016-07-01There have been now prerequisites for changing the scientific view of the etiology and pathogenesis of spondyloarthritis (SpA). An important role is assigned to the dysfunction and disintegration of the so-called barrier organs that make protection of man between his internal milieu and the environm...
Get full text
Article -
2
MODERN IDEA ON THE PATHOGENESIS OF SPONDYLOARTHRITIS: MOLECULAR MECHANISMS by E. L. Nasonov, E. A. Galushko, A. V. Gordeev
Published 2015-09-01As of now, impaired immune homeostasis of the intestinal mucosa in genetically predisposed individuals is considered to be one of the major components in the pathogenesis of spondyloarthritis (SpA), which leads to systemic chronic inflammation. The results of recent studies may suggest that the inte...
Get full text
Article -
3
Fever of unknown origin in rheumatology by A. V. Gordeev, N. M. Savushkina, E. A. Galushko
Published 2018-06-01The article considers the current state of the problem related to fever of unknown origin (FUO). It highlights the main stages of studying this issue with a detailed description of the classification diagnostic criteria, etiological types, and clinical signs of certain types of FUO, which have under...
Get full text
Article -
4
The impact of cigarette smoking and smoking cessation on risk and phenotype of rheumatoid arthritis by E. G. Zotkin, E. V. Pozhidaev, A. V. Gordeev
Published 2024-12-01Literature review presents the data of recent scientific studies aimed to analyze the impact of cigarette smoking on the risk of rheumatoid arthritis (RA). It is shown the main mechanisms of interaction between genetic constitution, synthesis of RA-specific antibodies, and other immune trait under t...
Get full text
Article -
5
Assessing the status of patients with rheumatoid arthritis: modern tendencies by A. M. Lila, Yu. A. Olyunin, A. V. Gordeev
Published 2020-05-01Assessing the status of a patient with rheumatoid arthritis allows one to obtain information necessary to choose appropriate management tactics for the patient. The use of quantitative methods in routine practice to determine inflammatory activity is the basis for the development of standardized pat...
Get full text
Article -
6
THE CONCEPT OF MULTIMORBIDITY IN RHEUMATOLOGIC PRACTICE by A. V. Gordeev, E. A. Galushko, E. L. Nasonov
Published 2014-09-01The undoubted and legitimate interest of investigators in comorbidities in rheumatic diseases has not faded in the past decade; however, the concept of multimorbidity has not yet been integrated into either clinical practice or rheumatology researches. The terms comorbidity and multimorbidity are fr...
Get full text
Article -
7
The role of microbiome in the pathogenesis of immune-mediated inflammatory diseases: controversial issues by A. M. Lila, E. A. Galushko, A. V. Gordeev, A. S. Semashko
Published 2021-02-01Increasing attention in rheumatology is today paid to the detection of diseases at the earliest possible (preclinical) stages, which can contribute to a more favorable response to therapy. The preclinical period of a systemic autoimmune reaction is assumed to be related to dysregulation of immune in...
Get full text
Article -
8
On the advisability of long-term use of low-dose glucocorticoids in elderly patients with rheumatoid arthritis by A. V. Gordeev, E. V. Matyanova, E. G. Zotkin, A. M. Lila
Published 2025-06-01In managing elderly patients with rheumatoid arthritis (RA), it is essential to maintain a balance between treatment efficacy and safety, particularly concerning the use of glucocorticoids (GCs). Despite decades of GC use in comprehensive RA therapy, questions regarding the optimal safe dose, treatm...
Get full text
Article -
9
Multimorbidity in rheumatology. From comprehensive assessment of disease to evaluation of a set of diseases by A. M. Lila, A. V. Gordeev, Yu. A. Olyunin, E. A. Galushko
Published 2019-09-01The World Health Organization assigns cardiovascular diseases, cancers, chronic respiratory diseases, as well as diabetes mellitus and some other nosological entities, including mental and musculoskeletal disorders, to main non-communicable diseases. These are considered to be a major public health...
Get full text
Article -
10
Severe myocarditis as a cause of the formation of cardiorenal syndrome in a patient with refractory rheumatoid arthritis by Z. Yu. Mutovina, A. V. Gordeev, I. V. Rozanova, E. A. Galushko
Published 2022-09-01According to modern concepts, myocarditis is an inflammatory disease of the myocardium, diagnosed on the basis of generally accepted histological, immunological, immunohistochemical criteria. Previously, most researchers believed that the most common cardiac extra-articular manifestation of rheumato...
Get full text
Article -
11
POLYMYALGIA RHEUMATICA by A. M. Satybaldyev, N. V. Demidova, N. M. Savushkina, A. V. Gordeev
Published 2018-05-01The lecture presents an update on the epidemiology, pathogenesis, clinical manifestations, diagnosis, differential diagnosis, and treatment stages of polymyalgia rheumatica, a chronic inflammatory disease of unknown etiology, which affects older people.----Authors of the article «Rheumatic polimyalg...
Get full text
Article -
12
Angiotensins and rheumatoid arthritis by N. M. Savushkina, E. A. Galushko, N. V. Demidova, A. V. Gordeev
Published 2019-01-01At present, the role of the renin-angiotensin system (RAS) in regulating the cardiovascular system and maintaining water and electrolyte homeostasis has been well studied. However, over the past decades, new components of the RAS have been identified, suggesting a wider range of its potential effect...
Get full text
Article -
13
CURRENT VIEWS ON THE HETEROGENEITY OF RENAL INVOLVEMENTS IN PATIENTS WITH SYSTEMIC SCLEROSIS by A. V. Gordeev, A. Yu. Zakharova, Z. Yu. Mutovina, L. P. Ananyeva
Published 2015-09-01Systemic sclerosis (SS), is an autoimmune connective tissue disease, the main clinical signs of which are due to disseminated microcirculatory disorders and fibrosis of the skin and viscera. Morphological examinations showed that 80% of patients with SS had renal changes, including those unassociate...
Get full text
Article -
14
IS PERIODONTITIS A HARBINGER OF RHEUMATOID ARTHRITIS? by A. V. Gordeev, E. A. Galushko, N. M. Savushkina, A. M. Lila
Published 2018-11-01Increasing attention in rheumatology is currently paid to the detection of diseases in the earliest (preclinical) stages, which can contribute to a more favorable response to therapy. To this end, various clinical, laboratory (and primarily immunological) and instrumental parameters are studied as a...
Get full text
Article -
15
Cardiorenal syndrome in patients with rheumatoid arthritis by Z. Yu. Mutovina, A. I. Zagrebneva, E. A. Galushko, A. V. Gordeev
Published 2019-09-01In 2008, the term cardiorenal syndrome (CRS) was proposed by the Acute Dialysis Quality Initiative (ADQI) Group to denote pathological reciprocal conditions involving the heart and kidneys, which develop due to acute or chronic dysfunction of one of the organs, followed by acute or chronic dysfuncti...
Get full text
Article -
16
The use of hepcidin as a marker for diagnosing the type of anemia in patients with high activity of rheumatoid arthritis by A. S. Semashko, A. M. Lila, E. A. Galushko, A. V. Gordeev, E. G. Zotkin
Published 2023-12-01Anemia is still one of the most common comorbidities that affects the prognosis of the underlying disease and the quality of life of patients.Objective: to evaluate the value of serum hepcidin level determination for the differential diagnosis of anemia of chronic disease/inflammation (ACD) in patie...
Get full text
Article -
17
Assessing the multimorbid profile (CIRS) in rheumatoid arthritis. First results by A. V. Gordeev, E. A. Galushko, N. M. Savushkina, N. V. Demidova, A. S. Semashko
Published 2019-09-01Objective: to assess the presence and nature of multimorbidity in patients with rheumatoid arthritis (RA) and the impact of multimorbidity on disease activity.Patients and methods. The investigation enrolled 117 patients (mean age, 54.8+14.8years) with RA according to the 2010 ACR/EULAR criteria, wh...
Get full text
Article -
18
Difficult-to-treat rheumatoid arthritis in the clinical practice of a rheumatological hospital. First look by A. V. Gordeev, E. V. Matyanova, Yu. A. Olyunin, E. A. Galushko, E. G. Zotkin
Published 2022-05-01Objective: to compare the course of the disease and therapy in rheumatoid arthritis (RA) patients who meet and do not meet the criteria for difficult- to-treat RA (D2T).Patients and methods. The study included RA patients who met the 2010 ACR/EULAR criteria and who were hospitalized in the V.A. Naso...
Get full text
Article -
19
Difficult-to-treat rheumatoid arthritis. What is it? by A. V. Gordeev, Yu. A. Olyunin, E. A. Galushko, E. G. Zotkin, A. M. Lila
Published 2021-10-01The widespread introduction into clinical practice of modern approaches to the treatment of rheumatoid arthritis (RA), the rational use of traditional and targeted antirheumatic drugs can effectively suppress inflammatory activity, restrain the progression of the disease and improve the quality of l...
Get full text
Article -
20
"Atherosclerotic" phenotype of rheumatoid arthritis. What do we know about it? by A. V. Gordeev, E. V. Matyanova, E. V. Pozhidaev, E. G. Zotkin, A. M. Lila
Published 2024-10-01Several studies have shown that systemic rheumatoid inflammation may cause induction and accelerated progression of atherosclerotic vascular lesions, which in turn may lead to more frequent development of cardiovascular diseases (CVD) in patients with rheumatoid arthritis (RA) compared to the genera...
Get full text
Article